Boston Scientific Corporation (BSX)

Last Price: 35.38 (2020-07-02)

Company Description

Boston Scientific Corporation transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader they advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $10.73B
Net Income (Most Recent Fiscal Year) $4.70B
PE Ratio (Current Year Earnings Estimate) 39.39
PE Ratio (Trailing 12 Months) 23.28
PEG Ratio (Long Term Growth Estimate) 3.69
Price to Sales Ratio (Trailing 12 Months) 4.59
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 3.58
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) 14.72
Pre-Tax Margin (Trailing 12 Months) 2.34%
Net Margin (Trailing 12 Months) 39.75%
Return on Equity (Trailing 12 Months) 18.24%
Return on Assets (Trailing 12 Months) 7.64%
Current Ratio (Most Recent Fiscal Quarter) 1.21
Quick Ratio (Most Recent Fiscal Quarter) 0.80
Debt to Common Equity (Most Recent Fiscal Quarter) 0.68
Inventory Turnover (Trailing 12 Months) 2.10
Book Value per Share (Most Recent Fiscal Quarter) $9.96
Earnings per Share (Most Recent Fiscal Quarter) $0.28
Earnings per Share (Most Recent Fiscal Year) $1.58
Diluted Earnings per Share (Trailing 12 Months) $3.04
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Common Shares Outstanding 1.40B
Free Float 1.39B
Market Capitalization $49.51B
Average Volume (Last 20 Days) 12.11M
Beta (Past 60 Months) 0.92
Percentage Held By Insiders (Latest Annual Proxy Report) 0.70%
Percentage Held By Institutions (Latest 13F Reports) 90.10%
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%